Zejula-Bevacizumab Combo Delays Progression in Relapsed Ovarian Cancer, Trial Finds
News
A combination of bevacizumab and Zejula (niraparib) is significantly better than Zejula alone at extending the time without disease progression in people with platinum-sensitive relapsed ovarian cancer, findings from a clinical ... Read more